BR0315209A - Formulações nutritivas que contêm substâncias simbióticas - Google Patents

Formulações nutritivas que contêm substâncias simbióticas

Info

Publication number
BR0315209A
BR0315209A BR0315209-0A BR0315209A BR0315209A BR 0315209 A BR0315209 A BR 0315209A BR 0315209 A BR0315209 A BR 0315209A BR 0315209 A BR0315209 A BR 0315209A
Authority
BR
Brazil
Prior art keywords
formulations containing
nutritional formulations
substances
containing symbiotic
symbiotic substances
Prior art date
Application number
BR0315209-0A
Other languages
English (en)
Inventor
Susan Marie Kaup
Jeffrey Lynn Wilson
Beverley Marie Kostek
David Curtis Frantz
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BR0315209A publication Critical patent/BR0315209A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/113—Acidophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

"FORMULAçõES NUTRITIVAS QUE CONTêM SUBSTâNCIAS SIMBIóTICAS". A presente invenção refere-se a composições nutritivas que compreendem oligofrutose, sialillactose e bactérias probióticas, que são úteis para a erradicação de mocroorganismos patogênicos no trato gastrointestinal de pacientes.
BR0315209-0A 2002-10-11 2003-10-08 Formulações nutritivas que contêm substâncias simbióticas BR0315209A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41810902P 2002-10-11 2002-10-11
PCT/US2003/031928 WO2004032639A1 (en) 2002-10-11 2003-10-08 Nutritional formulations containing synbiotic substances

Publications (1)

Publication Number Publication Date
BR0315209A true BR0315209A (pt) 2005-08-16

Family

ID=32094146

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0315209-0A BR0315209A (pt) 2002-10-11 2003-10-08 Formulações nutritivas que contêm substâncias simbióticas

Country Status (13)

Country Link
US (1) US20040072794A1 (pt)
EP (1) EP1549151A1 (pt)
CN (1) CN1703149A (pt)
AU (1) AU2003282494A1 (pt)
BR (1) BR0315209A (pt)
CA (1) CA2500366A1 (pt)
EC (1) ECSP055725A (pt)
MX (1) MXPA05003597A (pt)
NO (1) NO20051651L (pt)
NZ (1) NZ539862A (pt)
OA (1) OA13142A (pt)
PL (1) PL375071A1 (pt)
WO (1) WO2004032639A1 (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0410785D0 (en) * 2004-05-14 2004-06-16 Glycologic Ltd Improved prebiotic
FR2877844B1 (fr) * 2004-11-18 2008-05-09 United Pharmaceuticals Sa Sa Composition contenant un probiotique destinee a l'alimentation infantile chez des sujets souffrant de diarrhees
MX2007012697A (es) 2005-04-13 2008-01-14 Nestec Sa Formula para infantes con probioticos.
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US8287931B2 (en) * 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
BRPI0618261A2 (pt) * 2005-11-04 2011-08-23 Arla Foods Amba concentrado e composição derivados de um produto de leite enriquecido em sialil-lactose que ocorre naturalmente, processo para preparação dos mesmos e produto
US9005682B2 (en) 2006-03-07 2015-04-14 Nestec S.A. Synbiotic mixture
EP2004201B1 (en) * 2006-03-29 2018-08-08 Nestec S.A. Dietary supplements containing probiotics
WO2007114683A1 (en) * 2006-03-30 2007-10-11 N.V. Nutricia Milk oligosaccharides for stimulating the immune system
WO2008042101A2 (en) 2006-10-02 2008-04-10 Danisco A/S Probiotics for use in reducing the incidence and duration of illness
ES2668552T3 (es) * 2007-03-21 2018-05-18 Nestec S.A. Sistema de seguridad para composiciones nutricionales en polvo
EP2060257A1 (en) * 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
WO2009151315A1 (en) * 2008-06-13 2009-12-17 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
CN102065867A (zh) * 2008-06-13 2011-05-18 N.V.努特里奇亚 预防感染的营养物
WO2010002241A1 (en) * 2008-06-30 2010-01-07 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8425955B2 (en) 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
CA2760999A1 (en) * 2009-03-13 2010-09-16 Mariana Barboza Prebiotic oligosaccharides
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
BR112013013777B1 (pt) * 2010-12-06 2019-10-29 Nutricia Nv método não terapêutico e composição nutricional para bebês
WO2012092153A1 (en) 2010-12-31 2012-07-05 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
US8802650B2 (en) * 2010-12-31 2014-08-12 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
SG191394A1 (en) 2010-12-31 2013-08-30 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
EP2658548B1 (en) 2010-12-31 2018-02-21 Abbott Laboratories Human milk oligosaccharides for modulating inflammation
EP2658400A2 (en) 2010-12-31 2013-11-06 Abbott Laboratories Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
EP3335576A1 (en) 2010-12-31 2018-06-20 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
MY197622A (en) 2010-12-31 2023-06-28 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
US10639319B2 (en) 2011-08-29 2020-05-05 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
NL2007931C2 (en) 2011-12-07 2013-06-10 Friesland Brands Bv Methods for providing sialylated oligosaccharides and products obtainable thereby.
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
WO2015077233A1 (en) 2013-11-19 2015-05-28 Abbott Laboratories Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides
ES2802985T3 (es) * 2014-08-08 2021-01-22 Nestle Sa Vitamina B2 y mioinositol para el tratamiento y la prevención de la diabetes gestacional
WO2016020491A1 (en) * 2014-08-08 2016-02-11 Nestec S.A. Myo-inositol and probiotics, and their use

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260280A (en) * 1989-02-07 1993-11-09 Snow Brand Milk Products Co., Ltd. Bacterial toxin neutralizer
ATE198702T1 (de) * 1991-11-25 2001-02-15 Richardson Vicks Inc Verwendungvon salicylsäure zur kontrolle der hautatrophie
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
MX9304638A (es) * 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
DE69530910D1 (de) * 1994-07-15 2003-07-03 Taiyo Kagaku Co Medizinische zusammensetzungen enthaltend ein sialinsäurederivat
FI102807B (fi) * 1994-08-25 1999-02-26 Valio Oy Lactobacillus rhamnosuksen käyttö elintarviketeollisuudessa klostridie n estoon
US6241983B1 (en) * 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
US5688777A (en) * 1995-04-05 1997-11-18 Abbott Laboratories Inhibition of C. difficile infections by indigestible oligosaccharides
US5849324A (en) * 1995-07-10 1998-12-15 Abbott Laboratories Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans
US5827526A (en) * 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
US6030650A (en) * 1996-11-22 2000-02-29 Princeton Nutrition, L.L.C. Complete nutritional milk compositions and products
DE19701382A1 (de) * 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
US5902743A (en) * 1998-03-20 1999-05-11 Wisconsin Alumni Research Foundation Probiotic bifidobacterium strain
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
US6630452B2 (en) * 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
TWI265008B (en) * 2000-02-17 2006-11-01 Wyeth Corp Nutritional formulation comprising oligofructose and sialyllactose

Also Published As

Publication number Publication date
OA13142A (en) 2006-12-13
NO20051651L (no) 2005-05-06
CN1703149A (zh) 2005-11-30
EP1549151A1 (en) 2005-07-06
WO2004032639A1 (en) 2004-04-22
AU2003282494A1 (en) 2004-05-04
NZ539862A (en) 2006-05-26
CA2500366A1 (en) 2004-04-22
MXPA05003597A (es) 2005-06-03
PL375071A1 (en) 2005-11-14
ECSP055725A (es) 2005-07-06
US20040072794A1 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
BR0315209A (pt) Formulações nutritivas que contêm substâncias simbióticas
UY26734A1 (es) Nuevos probióticos para aplicaciones de alimento de mascotas
BRPI0417826A (pt) bifidobactéria pseudolongum probiótica canina
BRPI0417793A (pt) bifidobactéria globosum probiótica canina
TW200514847A (en) Lactic acid bacteria having mucosal immunopotentiation effect
HUP0303728A2 (hu) Tápanyagkészítmény
ATE534396T1 (de) Probiotische mikroorganismen zur verbesserung der muskulären funktion
EP1930407A4 (en) NOVEL BACTERIUM BELONGING TO THE GENUS BIFIDOBACTERIUM AND USE THEREOF
ATE335071T1 (de) Bakterien der gattung bifidobacterium longum und bakterien enthaltende zusammensetzung
DE69924141D1 (de) Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
BRPI0108478B8 (pt) composição nutritiva contendo substancias pré-bióticas
EP2586427A3 (en) Balsalazide formulations and manufacture thereof
BR0314511A (pt) Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
ATE354964T1 (de) Probiotische zusammensetzung mit mindestens zwei milchsäurebakterienstämmen, die zur kolonisierung des magen-darm-trakts fähig sind und in kombination damit die eigenschaften, im darm zu überleben, an den darm zu binden, gegen infektion zu schützen und ballaststoffe zu fermentieren, aufweisen
WO2008127361A3 (en) Synthesis of enone intermediate
MXPA02011476A (es) Fuente de triptofano de plantas y usos para el mismo.
WO2000007606A3 (en) Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria
CA2556520A1 (en) Chromium-fatty acid compounds and methods of making and using thereof
BR0211453A (pt) Composição sólida que contém esporos de bactérias não patogênicas do gênero bacillus
MXPA04005346A (es) Uso de microorganismos para una distribucion dirigida de sustancias a partes especificas del intestino.
BRPI0408848A (pt) formulações orais de cladribine
BRPI0409609A (pt) mediadores do transporte reverso de colesterol para o tratamento da hipercolesterolemia
PT1292570E (pt) Sal de creatina que possui uma eficacia nutricional e terapeutica melhorada e composicoes que o contem
NO20014788D0 (no) En sammensetning for senkning av konsentrasjonen av sykdomsfremkallende tarmpeptider
PL1615656T3 (pl) Produkt immunomodulatorowy otrzymany z hodowli bifidobacterium i zawierające go kompozycje

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A , 6A , E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2073 DE 28/09/2010.

B15K Others concerning applications: alteration of classification

Ipc: A23L 33/135 (2016.01), A23L 29/244 (2016.01), A23L